Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MacAndrews & Forbes is a private holding company owned by Ronald Perelman that manages a diverse portfolio of investments, with a significant emphasis on the life sciences and healthcare sectors. The firm's healthcare strategy is primarily executed through its major holdings in companies such as SIGA Technologies, a commercial-stage pharmaceutical company focused on health security and antiviral treatments like TPOXX, and vTv Therapeutics, which develops small molecule candidates for metabolic and neurological diseases. MacAndrews & Forbes provides strategic direction and long-term capital to its subsidiaries, driving the development of therapies for high-priority infectious diseases and chronic conditions. The company has a long history of acquiring and scaling businesses across the pharmaceutical, biotechnology, and consumer health industries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MacAndrews.